[go: up one dir, main page]

UY29657A1 - DERIVATIVES OF N - ((1,5-DIFENIL-1H-PIRAZOL-3-IL) METHYL) SULFONAMIDE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS - Google Patents

DERIVATIVES OF N - ((1,5-DIFENIL-1H-PIRAZOL-3-IL) METHYL) SULFONAMIDE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Info

Publication number
UY29657A1
UY29657A1 UY29657A UY29657A UY29657A1 UY 29657 A1 UY29657 A1 UY 29657A1 UY 29657 A UY29657 A UY 29657A UY 29657 A UY29657 A UY 29657A UY 29657 A1 UY29657 A1 UY 29657A1
Authority
UY
Uruguay
Prior art keywords
sulfonamide
therapeutics
methyl
preparation
application
Prior art date
Application number
UY29657A
Other languages
Spanish (es)
Inventor
Christian Congy
Murielle Rinaldi-Carmona
Philippe Pointeau
Barth Francis
Martinez Serge
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY29657A1 publication Critical patent/UY29657A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención tiene como objeto los compuestos de la fórmula (I), derivados nuevos de N-((1,5-difenil-1H-pirazol-3-il)metil)sulfonamida, en la que los radicales y sustituyentes son los especificados en la Memoria Descriptiva y en las reivindicaciones; así como al procedimiento de preparación y aplicación en terapéutica.The present invention is directed to the compounds of the formula (I), novel derivatives of N - ((1,5-diphenyl-1 H -pyrazol-3-yl) methyl) sulfonamide, in which the radicals and substituents are those specified in the Descriptive Report and in the claims; as well as the procedure of preparation and application in therapeutics.

UY29657A 2005-07-08 2006-07-07 DERIVATIVES OF N - ((1,5-DIFENIL-1H-PIRAZOL-3-IL) METHYL) SULFONAMIDE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS UY29657A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0507360A FR2888236B1 (en) 2005-07-08 2005-07-08 N - [(1,5-DIPHENYL-1H-PYRAZOL-3-YL) METHYL] SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

Publications (1)

Publication Number Publication Date
UY29657A1 true UY29657A1 (en) 2007-01-31

Family

ID=35872804

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29657A UY29657A1 (en) 2005-07-08 2006-07-07 DERIVATIVES OF N - ((1,5-DIFENIL-1H-PIRAZOL-3-IL) METHYL) SULFONAMIDE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Country Status (7)

Country Link
AR (1) AR057660A1 (en)
DO (1) DOP2006000163A (en)
FR (1) FR2888236B1 (en)
GT (1) GT200600296A (en)
PE (1) PE20070175A1 (en)
TW (1) TW200800910A (en)
UY (1) UY29657A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297710B1 (en) 2006-07-12 2007-11-20 Sanofi-Aventis Derivatives of N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide, their preparation and their application in therapeutics
FR2911136B1 (en) * 2007-01-05 2009-02-20 Sanofi Aventis Sa SUBSTITUTED N- (4-CYANO-1H-PYRAZOL-3-YL) METHYLAMINE DERIVATIVES AND THEIR PREPARATION AND THERAPEUTIC USE THEREOF
JP4994295B2 (en) * 2007-04-20 2012-08-08 田辺三菱製薬株式会社 Pharmaceutical composition
CN113200850A (en) * 2021-05-08 2021-08-03 渭南师范学院 Preparation method of alpha-acyloxyketone compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (en) * 1993-12-02 1996-03-01 Sanofi Sa Substituted N-piperidino-3-pyrazolecarboxamide.
US7247628B2 (en) * 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
FR2856683A1 (en) * 2003-06-25 2004-12-31 Sanofi Synthelabo 4-CYANOPYRAZOLE-3-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
GT200600296A (en) 2007-03-14
AR057660A1 (en) 2007-12-12
FR2888236B1 (en) 2007-09-21
PE20070175A1 (en) 2007-02-23
TW200800910A (en) 2008-01-01
DOP2006000163A (en) 2007-02-15
FR2888236A1 (en) 2007-01-12

Similar Documents

Publication Publication Date Title
CL2009000323A1 (en) Compounds derived from substituted non-condensed heterocycles, inhibitors of the ns5a protein function; pharmaceutical composition comprising them; and its use to treat hepatitis c virus infection.
GT200600134A (en) NEW COMPOUNDS OF AMINOSULPHONYL DERIVATIVES
CL2009000324A1 (en) Compounds derived from substituted non-condensed heterocycles, inhibitors of the ns5a protein function; pharmaceutical composition comprising them; and its use to treat hepatitis c virus infection.
UY30498A1 (en) NEW CLASS OF BENZIMIDAZOLILO COMPOUNDS, ITS SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
EA200702002A1 (en) REPLACED DERIVATIVES OF PYRAZOLYLOXYPHENYL, USED AS HERBICIDES
ECSP088677A (en) PIPERAZINAS AND PIPERIDINAS AS POTENCIADORES 157 OF THE MGLUR5
NO20074718L (en) BCRP / ABCG2 inhibitor
EA201070424A1 (en) HINAZOLINDION DERIVATIVES, THEIR OBTAINING AND THEIR APPLICATION IN THERAPY
UY31036A1 (en) DERIVATIVES OF TRIAZOLOPIRIDINA-CARBOXAMIDAS, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION
CR8312A (en) NEW SULFONAMIDS AS PHYTOSANITARY AGENTS
GT200900309A (en) DERIVATIVES OF 7-ALQUINIL-1,8-NAFTIRIDONAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
CR20110381A (en) CCR2 4-AZETIDINIL-1-HETEROARIL-CICLOHEXANOL ANTAGONISTS
CO2022003062A2 (en) heterocyclic compounds
UY30285A1 (en) DERIVATIVES OF AMINOMETILIPIRINE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
ATE478054T1 (en) BENZIMIDAZOLE DERIVATIVES
DOP2006000045A (en) DERIVATIVES OF (1,5-DIFENIL-1H-PIRAZOL-3-IL OXADIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
UY29690A1 (en) DERIVATIVES OF N- (HETEROARIL) -1-HETEROARILALQUIL-1H-INDOL-2-CARBOXAMIDES, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS.
UY29767A1 (en) BENZOTIAZOLONAS DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
EA200901402A1 (en) THERAPEUTICOL AGAINST GLAUCOMA, CONTAINING AS Adenosine Derivative as an Active Ingredient
HRP20090474T1 (en) PROCEDURE AND INTERMEDIATES FOR SYNTHESIS OF KASPOFUNGIN
HN2010000330A (en) DERIVATIVES OF INDOL-2-ONA DISPOSED IN 3 AND ITS PREPARATION
CR9391A (en) DERIVATIVES OF INDANIL-PIPERAZINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY29518A1 (en) DERIVATIVES OF RENT-, ALQUENIL- AND ALQUINILCARBAMATOS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS.
ECSP099679A (en) NEW COMPOUNDS AND THEIR USES 707
EA200970497A1 (en) PYRROLA DERIVATIVES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120510